The 73 kDa subunit of the CPSF complex binds to the HIV-1 LTR promoter and functions as a negative regulatory factor that is inhibited by the HIV-1 Tat protein.

[1]  L. Tong,et al.  Polyadenylation factor CPSF-73 is the pre-mRNA 3'-end-processing endonuclease , 2006, Nature.

[2]  D. Harrich,et al.  Will diverse Tat interactions lead to novel antiretroviral drug targets? , 2006, Current drug targets.

[3]  Eric Verdin,et al.  The SWI/SNF Chromatin-remodeling Complex Is a Cofactor for Tat Transactivation of the HIV Promoter* , 2006, Journal of Biological Chemistry.

[4]  J. Steitz,et al.  Symplekin and multiple other polyadenylation factors participate in 3'-end maturation of histone mRNAs. , 2005, Genes & development.

[5]  Mohamed-Ali Hakimi,et al.  Integrator, a Multiprotein Mediator of Small Nuclear RNA Processing, Associates with the C-Terminal Repeat of RNA Polymerase II , 2005, Cell.

[6]  Z. Dominski,et al.  The Polyadenylation Factor CPSF-73 Is Involved in Histone-Pre-mRNA Processing , 2005, Cell.

[7]  Mary K. Lewinski,et al.  Molecular mechanisms of HIV-1 proviral latency , 2005, Expert review of anti-infective therapy.

[8]  K. Khalili,et al.  p73 Interacts with Human Immunodeficiency Virus Type 1 Tat in Astrocytic Cells and Prevents Its Acetylation on Lysine 28 , 2005, Molecular and Cellular Biology.

[9]  D. Trouche,et al.  HIV‐1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses , 2005, The EMBO journal.

[10]  S. Petrini,et al.  A review of HIV‐1 Tat protein biological effects , 2005, Cell biochemistry and function.

[11]  C. Van Lint,et al.  HIV-1 Tat Interactions with p300 and PCAF Transcriptional Coactivators Inhibit Histone Acetylation and Neurotrophin Signaling through CREB* , 2005, Journal of Biological Chemistry.

[12]  E. Wagner,et al.  A CPSF-73 Homologue Is Required for Cell Cycle Progression but Not Cell Growth and Interacts with a Protein Having Features of CPSF-100 , 2005, Molecular and Cellular Biology.

[13]  M. Calzado,et al.  Human Immunodeficiency Virus Type 1 Tat Increases the Expression of Cleavage and Polyadenylation Specificity Factor 73-Kilodalton Subunit Modulating Cellular and Viral Expression , 2004, Journal of Virology.

[14]  B. Fiebich,et al.  Immunosuppressive Activity of Endovanilloids: N-Arachidonoyl-Dopamine Inhibits Activation of the NF-κB, NFAT, and Activator Protein 1 Signaling Pathways 1 , 2004, The Journal of Immunology.

[15]  W. Keller,et al.  Human Fip1 is a subunit of CPSF that binds to U‐rich RNA elements and stimulates poly(A) polymerase , 2004, The EMBO journal.

[16]  C. Samuel,et al.  The PKR kinase promoter binds both Sp1 and Sp3, but only Sp3 functions as part of the interferon-inducible complex with ISGF-3 proteins. , 2003, Virology.

[17]  F. Kashanchi,et al.  Chromatin remodeling and modification during HIV-1 Tat-activated transcription. , 2003, Current HIV research.

[18]  T. Rana,et al.  A bimolecular mechanism of HIV-1 Tat protein interaction with RNA polymerase II transcription elongation complexes. , 2002, Journal of molecular biology.

[19]  D. Bentley.  The mRNA assembly line: transcription and processing machines in the same factory. , 2002, Current opinion in cell biology.

[20]  A. Furger,et al.  Integrating mRNA Processing with Transcription , 2002, Cell.

[21]  S. Nekhai,et al.  TFIIH Inhibits CDK9 Phosphorylation during Human Immunodeficiency Virus Type 1 Transcription* , 2001, The Journal of Biological Chemistry.

[22]  Masatoshi Watanabe,et al.  The Role of Epigenetic Modifications in Retinoic Acid Receptor β2 Gene Expression in Human Prostate Cancers , 2001, Laboratory Investigation.

[23]  A. Jordan,et al.  The site of HIV‐1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation , 2001, The EMBO journal.

[24]  M. Churchill,et al.  A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. , 2000, Nucleic acids research.

[25]  D. Aunis,et al.  Functional Interactions between C/EBP, Sp1, and COUP-TF Regulate Human Immunodeficiency Virus Type 1 Gene Transcription in Human Brain Cells , 2000, Journal of Virology.

[26]  Jing Zhao,et al.  Formation of mRNA 3′ Ends in Eukaryotes: Mechanism, Regulation, and Interrelationships with Other Steps in mRNA Synthesis , 1999, Microbiology and Molecular Biology Reviews.

[27]  K. Jeang,et al.  Modulation of Sp1 Phosphorylation by Human Immunodeficiency Virus Type 1 Tat , 1998, Journal of Virology.

[28]  Ping Wei,et al.  A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA , 1998, Cell.

[29]  D. Aunis,et al.  COUP-TF and Sp1 Interact and Cooperate in the Transcriptional Activation of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat in Human Microglial Cells* , 1997, The Journal of Biological Chemistry.

[30]  J. Manley,et al.  Mechanism and regulation of mRNA polyadenylation. , 1997, Genes & development.

[31]  D. Hazuda,et al.  P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. , 1997, Genes & development.

[32]  M. Mathews,et al.  Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. , 1997, Genes & development.

[33]  J. Dantonel,et al.  Transcription factor TFIID recruits factor CPSF for formation of 3′ end of mRNA , 1997, Nature.

[34]  L. Minvielle-Sebastia,et al.  A comparison of mammalian and yeast pre-mRNA 3'-end processing. , 1997, Current opinion in cell biology.

[35]  R. Paro,et al.  Analysis of chromatin structure by in vivo formaldehyde cross-linking. , 1997, Methods.

[36]  L. Minvielle-Sebastia,et al.  Sequence Similarity Between the 73-Kilodalton Protein of Mammalian CPSF and a Subunit of Yeast Polyadenylation Factor I , 1996, Science.

[37]  K. Jeang,et al.  Requirements for RNA Polymerase II Carboxyl-terminal Domain for Activated Transcription of Human Retroviruses Human T-Cell Lymphotropic Virus I and HIV-1* , 1996, The Journal of Biological Chemistry.

[38]  A. Peeters,et al.  A fourth Sp1 site in the human immunodeficiency virus type 1 long terminal repeat is essential for negative-sense transcription , 1996, Journal of virology.

[39]  G. Carmichael,et al.  Role of polyadenylation in nucleocytoplasmic transport of mRNA , 1996, Molecular and cellular biology.

[40]  J. Laurence,et al.  Role of glucocorticoid receptor binding sites in the human immunodeficiency virus type 1 long terminal repeat in steroid-mediated suppression of HIV gene expression. , 1995, Virology.

[41]  K. Murthy,et al.  The 160-kD subunit of human cleavage-polyadenylation specificity factor coordinates pre-mRNA 3'-end formation. , 1995, Genes & development.

[42]  W. Keller,et al.  No end yet to messenger RNA 3′ processing! , 1995, Cell.

[43]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[44]  K. Jeang,et al.  In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor , 1993, Journal of virology.

[45]  C. Van Lint,et al.  Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. , 1993, The EMBO journal.

[46]  M. Imperiale,et al.  Relative roles of signals upstream of AAUAAA and promoter proximity in regulation of human immunodeficiency virus type 1 mRNA 3' end formation , 1992, Molecular and cellular biology.

[47]  J S Wall,et al.  DNA looping and Sp1 multimer links: a mechanism for transcriptional synergism and enhancement. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. Tjian,et al.  DNA looping between sites for transcriptional activation: self-association of DNA-bound Sp1. , 1991, Genes & development.

[49]  D. Hudson,et al.  Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition. , 1991, Genes & development.

[50]  J. Sodroski,et al.  The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat , 1985, Cell.

[51]  R. Gaynor.  Regulation of HIV-1 gene expression by the transactivator protein Tat. , 1995, Current topics in microbiology and immunology.

[52]  B. Graveley,et al.  CPSF recognition of an HIV-1 mRNA 3'-processing enhancer: multiple sequence contacts involved in poly(A) site definition. , 1995, Genes & development.